Literature DB >> 33653403

Incident gout and weight change patterns: a retrospective cohort study of US adults.

Lu Bai1, Jian-Bo Zhou2, Tao Zhou3, Roger B Newson4, Marly Augusto Cardoso5.   

Abstract

BACKGROUND: Although the relationship between obesity and incident gout has been clarified, the influence of weight changes during the transition from early adulthood to midlife and the different weight change patterns in specific age ranges on the incidence of gout in later life remain unknown. Therefore, we aimed to investigate the association between weight change patterns across adulthood and incident gout.
METHODS: Using data from the National Health and Nutrition Examination Survey (NHANES), we categorized individuals into four weight change patterns: those who remained obese (stable obese), those who moved from a non-obese body mass index (BMI) to an obese BMI (gaining), those who moved from an obese BMI to a non-obese BMI (losing), and those who remained non-obese (stable non-obese). Incident gout reflected its occurrence over the 10-year follow-up from the recalled midlife weight measure to the time of this survey. Hazard ratios (HRs) and 95% confidence intervals relating weight change patterns to incident gout over the 10-year follow-up period were calculated using Cox models adjusted for covariates. The hypothetical population attributable fraction (PAF) for the weight change patterns was calculated.
RESULTS: Among our sample of adults aged 40-74 years at their midlife weight measure (n = 11,079), 320 developed gout. The highest risk of incident gout was found for participants with the stable obese pattern (HR 1.84; 1.08-3.14) and not for participants who remained stable non-obese during adulthood. Moreover, gaining weight was a significant risk factor for incident gout (HR 1.65; 1.19-2.29). No significant associations were found between losing weight change patterns and the risk of gout during the study period. If participants who gained weight had become non-obese during the 10-year follow-up, an estimated 3.2% (95% CI 0-6.3) of observed gout cases could have been averted. In addition, if the population had maintained a normal BMI, 32.9% (95% CI 18.2-44.9) cases could have been prevented during the 10 years.
CONCLUSIONS: Gaining weight over adulthood was associated with an increased risk of gout. These findings have highlighted that maintaining non-obese weight and weight loss across adulthood is essential for the prevention and treatment of gout in adult life.

Entities:  

Keywords:  Cohort; Gout; Weight change

Mesh:

Year:  2021        PMID: 33653403      PMCID: PMC7923519          DOI: 10.1186/s13075-021-02461-7

Source DB:  PubMed          Journal:  Arthritis Res Ther        ISSN: 1478-6354            Impact factor:   5.156


  59 in total

1.  Use and misuse of population attributable fractions.

Authors:  B Rockhill; B Newman; C Weinberg
Journal:  Am J Public Health       Date:  1998-01       Impact factor: 9.308

2.  Gout and hyperuricaemia in the USA: prevalence and trends.

Authors:  Gurkirpal Singh; Bharathi Lingala; Alka Mithal
Journal:  Rheumatology (Oxford)       Date:  2019-12-01       Impact factor: 7.580

3.  Impact of bariatric surgery on serum urate targets in people with morbid obesity and diabetes: a prospective longitudinal study.

Authors:  Nicola Dalbeth; Peggy Chen; Marie White; Gregory D Gamble; Caran Barratt-Boyes; Peter J Gow; Brandon Orr-Walker
Journal:  Ann Rheum Dis       Date:  2013-11-19       Impact factor: 19.103

4.  Obesity, weight change, hypertension, diuretic use, and risk of gout in men: the health professionals follow-up study.

Authors:  Hyon K Choi; Karen Atkinson; Elizabeth W Karlson; Gary Curhan
Journal:  Arch Intern Med       Date:  2005-04-11

5.  Consumption of sugar sweetened beverages and dietary fructose in relation to risk of gout and hyperuricemia: a systematic review and meta-analysis.

Authors:  Soraiya Ebrahimpour-Koujan; Parvane Saneei; Bagher Larijani; Ahmad Esmaillzadeh
Journal:  Crit Rev Food Sci Nutr       Date:  2018-10-02       Impact factor: 11.176

Review 6.  Factors modulating the inflammatory response in acute gouty arthritis.

Authors:  Maartje C Cleophas; Tania O Crişan; Leo A B Joosten
Journal:  Curr Opin Rheumatol       Date:  2017-03       Impact factor: 5.006

7.  Sugar-sweetened soft drinks, diet soft drinks, and serum uric acid level: the Third National Health and Nutrition Examination Survey.

Authors:  Jee Woong J Choi; Earl S Ford; Xiang Gao; Hyon K Choi
Journal:  Arthritis Rheum       Date:  2008-01-15

Review 8.  Therapeutic approaches to chronic hyperuricemia and gout.

Authors:  Davide Grassi; Roberto Pontremoli; Raffaella Bocale; Claudio Ferri; Giovambattista Desideri
Journal:  High Blood Press Cardiovasc Prev       Date:  2014-04-03

9.  The validity of self-reports of past body weights by U.S. adults.

Authors:  G S Perry; T E Byers; A H Mokdad; M K Serdula; D F Williamson
Journal:  Epidemiology       Date:  1995-01       Impact factor: 4.822

Review 10.  The epidemiology and treatment of gout.

Authors:  Neil W McGill
Journal:  Open Access Rheumatol       Date:  2011-12-20
View more
  4 in total

Review 1.  Gout and Diet: A Comprehensive Review of Mechanisms and Management.

Authors:  Yingling Zhang; Simin Chen; Man Yuan; Yu Xu; Hongxi Xu
Journal:  Nutrients       Date:  2022-08-26       Impact factor: 6.706

Review 2.  Dietary and Lifestyle-Centered Approach in Gout Care and Prevention.

Authors:  Chio Yokose; Natalie McCormick; Hyon K Choi
Journal:  Curr Rheumatol Rep       Date:  2021-07-01       Impact factor: 4.686

3.  Medical Students' Perspective and Knowledge of Asymptomatic Hyperuricemia and Gout Management: A Cross-Sectional Study.

Authors:  Sanja Zuzic Furlan; Doris Rusic; Marko Kumric; Josko Bozic; Marino Vilovic; Tina Vilovic; Marko Rada; Venija Cerovecki; Marion Tomicic
Journal:  Healthcare (Basel)       Date:  2021-11-26

Review 4.  Where Epigenetics Meets Food Intake: Their Interaction in the Development/Severity of Gout and Therapeutic Perspectives.

Authors:  Philippe T Georgel; Philippe Georgel
Journal:  Front Immunol       Date:  2021-09-17       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.